Average Co-Inventor Count = 4.62
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (4 from 3,685 patents)
2. Bayer Healthcare LLC (4 from 778 patents)
8 patents:
1. 10717725 - Pyrrolidine GPR40 modulators
2. 9873679 - Pyrrolidine GPR40 modulators
3. 9604964 - Dihydropyrazole GPR40 modulators
4. 8829185 - Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
5. 8415367 - Pyrimidinylpiperidinyloxypyridinone analogues as GPR119 modulators
6. 8143393 - Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
7. 8133995 - Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
8. 8129379 - Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis